|
|
|
|
|
17.01.26 - 02:57
|
ROCKET DOCTOR AI INC. ANNOUNCES UPSIZE ON LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT (GlobeNewswire EN)
|
|
|
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States...
|
|
|
|
|
|
|
|
|
17.01.26 - 00:18
|
GBank Financial Holdings Inc. Announces Fourth Quarter 2025 Quarterly Earnings Call Scheduled for Wednesday, January 28th, at 2:00 P.M., Pacific Time (GlobeNewswire EN)
|
|
|
LAS VEGAS, Jan. 16, 2026 (GLOBE NEWSWIRE) -- GBank Financial Holdings Inc. (the "Company") (Nasdaq: GBFH), the parent company for GBank (the "Bank"), today announced it plans to release its fourth quarter 2025 financial results on Wednesday, January 28, 2026 at approximately 1:15 p.m. PST, and will host its quarterly earnings call on Wednesday, January 28, 2026, at 2:00 p.m. PST. Interested parties can participate remotely via Internet connectivity. There will be no physical location for attendance....
|
|
|
|
|
17.01.26 - 00:06
|
VERSES® Restructures to Focus on Core Target Market (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation agentic software systems, today announces a refocused corporate strategy designed to concentrate resources on the Company's core target markets and highest-priority initiatives....
|
|
|
|
|
16.01.26 - 23:18
|
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
SAN CARLOS, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on January 15, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 97,710 shares of Iovance's common stock to 17 new, non-executive employees....
|
|
|
|
|
16.01.26 - 23:12
|
Itafos Announces Appointment of New Director (GlobeNewswire EN)
|
|
|
HOUSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) (the “Company”) today announced the appointment of Joseph McConnell to its Board of Directors, effective January 16, 2026. Mr. McConnell replaces Isaiah Toback as a nominee to the Company's Board of Directors by its principal shareholder, CL Fertilizers Holding LLC (“CLF”), pursuant to an investor rights agreement between the Company and CLF....
|
|
|
16.01.26 - 23:09
|
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
BRISBANE, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on January 9, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4)....
|
|
|
|
|
16.01.26 - 23:03
|
DPM Metals Announces Filing of Technical Report for Rakita Camp Prospects (GlobeNewswire EN)
|
|
|
TORONTO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or “the Company”) announced that the Company has filed a technical report for its Dumitru Potok, Rakita North and Frasen prospects in Serbia (the “Report”). The purpose of the Report is to support the Inferred Mineral Resource estimate for the Dumitru Potok, Rakita North and Frasen prospects, as previously disclosed in the Company's news release dated December 2, 2025....
|
|
|
|
|
16.01.26 - 22:48
|
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
CHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on January 14, 2026, the Lifecore compensation committee approved grants under Lifecore's Equity Inducement Plan, as amended (the “Inducement Plan”) of restricted stock unit (“RSU”) awards with respect to an aggregate 1,738 shares of its common stock and stock options for an aggregate 8,775 shares of common stock to two newly hired employees of Lifecore. The RSU award and stock options were granted on January 14, 2026, pursuant to the offer letters between Lifecore and each employee, and as a material inducement to each employee joining Lifecore....
|
|
|
16.01.26 - 22:33
|
HCI Group Declares Quarterly Cash Dividend (GlobeNewswire EN)
|
|
|
TAMPA, Fla., Jan. 16, 2026 (GLOBE NEWSWIRE) -- The board of directors of HCI Group, Inc. (NYSE: HCI) has declared a regular quarterly cash dividend in the amount of 40 cents per common share. The dividend is scheduled to be paid March 20, 2026 to shareholders of record at the close of business February 20, 2026....
|
|
|
16.01.26 - 22:33
|
Carpenter Technology Declares Quarterly Cash Dividend (GlobeNewswire EN)
|
|
|
PHILADELPHIA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock, payable March 5, 2026, to shareholders of record on January 27, 2026....
|
|
|
16.01.26 - 22:33
|
Innovation Beverage Group Announces Receipt of Nasdaq Notice of Annual Shareholder Meeting Noncompliance (GlobeNewswire EN)
|
|
|
SYDNEY, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Innovation Beverage Group Ltd (“IBG” or the “Company”) (Nasdaq: IBG), an innovative developer, manufacturer, and marketer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands, announced today that on January 14, 2026, the Company received a notice from the Listing Qualifications Staff of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that as it did not hold an annual meeting of shareholders within twelve months of the end of the Company's fiscal year December 31, 2024, the Company is not in compliance with Nasdaq Listing Rules 5620(a), 5810(c)(2)(G), and IM-5620....
|
|